Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.800
-0.040 (-0.83%)
At close: Jan 9, 2026, 4:00 PM EST
4.978
+0.178 (3.70%)
After-hours: Jan 9, 2026, 7:40 PM EST
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $271.03 million as of January 9, 2026. Its market cap has increased by 52.02% in one year.
Market Cap
271.03M
Enterprise Value
191.25M
1-Year Change
52.02%
Ranking
Category
Stock Price
$4.80
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $271.03M, an increase of 37.27%. That is a compound annual growth rate of 6.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 271.03M | 15.66% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 968.32B |
| Johnson & Johnson | 494.92B |
| AbbVie | 393.10B |
| UnitedHealth Group | 311.93B |
| AstraZeneca | 295.31B |
| Merck & Co. | 276.45B |
| Novartis AG | 273.11B |
| Novo Nordisk | 256.73B |